Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6732)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 27, 2022 (publication date) through Aug 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cassese G, Han HS, Lee B, Lee HW, Cho JY, Panaro F, Troisi RI. Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease. World J Hepatol 2022; 14(10): 1862-1874 [PMID: 36340753 DOI: 10.4254/wjh.v14.i10.1862] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i10/1862.htm |
| Number | Citing Articles |
| 1 |
Satyam Yadav, Ranjeet Kumar. Gut Microbiota and the Gut-liver Axis in Hepatocellular Carcinoma: A Comprehensive Review of Pathogenesis and Therapeutic Strategies. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(17): 1287 doi: 10.2174/0118715206364200250304034753
|
| 2 |
Yanbing Dong, Ying Huang, Zhe Zhang, Aoxing Chen, Lin Li, Manman Tian, Jie Shen, Jie Shao. iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04024-7
|
| 3 |
Gianluca Cassese, Ho-Seong Han, Yoo-Seok Yoon, Jun Suh Lee, Boram Lee, Antonio Cubisino, Fabrizio Panaro, Roberto Ivan Troisi. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology 2023; 15(6): 911-924 doi: 10.4251/wjgo.v15.i6.911
Abstract(701) |
Core Tip(699) |
Full Article(HTML)(3257)
|
Full Article with Cover (PDF)-797K(208)
|
Full Article (Word)-180K(48)
|
Audio-186K(4)
|
Peer-Review Report-307K(97)
|
Answering Reviewers-39K(98)
|
Full Article (PDF)-493K(237)
|
Full Article (XML)-311K(124)
|
Times Cited (7)
|
Total Visits (7908)
|
Open
|
| 4 |
Gianluca Cassese, Ho-Seong Han, Jai Young Cho, Hae-Won Lee, Boram Lee, Roberto Ivan Troisi. Selecting the Best Approach for the Treatment of Multiple Non-Metastatic Hepatocellular Carcinoma. Cancers 2022; 14(23): 5997 doi: 10.3390/cancers14235997
|
| 5 |
Hongliang Ou, Yunsong Qian, Li Ma. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. Aging 2023; 15(13): 6100 doi: 10.18632/aging.204795
|
| 6 |
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
|
| 7 |
Shijing Tang, Hao Chen.
Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(3): 51 doi: 10.1615/JEnvironPatholToxicolOncol.2024050167
|